Glial and synaptic biomarkers as early indicators of mild cognitive decline
Our findings indicate that both proteins CX3CL1, as well as neurogranin, could be applied as complementary early biomarkers for more accurate diagnosing and stratification of patients with cognitive decline.
Authors
- Agnieszka Kulczyńska‐Przybik (ORCID: https://orcid.org/0000-0002-9889-3585)
- Daria Krawczuk (ORCID: https://orcid.org/0000-0002-6200-5232)
- Renata Borawska (ORCID: https://orcid.org/0000-0002-0448-2209)
- Jörg Hanrieder (ORCID: https://orcid.org/0000-0001-6059-198X)
- Julia Doroszkiewicz (ORCID: https://orcid.org/0000-0001-9937-4974)
- Barbara Mroczko (ORCID: https://orcid.org/0000-0002-4075-8479)
- Jan Mroczko
- Maciej Dulewicz (ORCID: https://orcid.org/0000-0002-7149-017X)
- Kaj Blennow
- Henrik Zetterberg
- Agnieszka Słowik
Institutions
- Jagiellonian University (PL)
- Medical University of Białystok (PL)
- University of Gothenburg (SE)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.088938
- Citations
- 1
- Primary Topic
- Health, Environment, Cognitive Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.31